Uncategorized

January 5, 2023

Virological characteristics of the SARS-CoV-2 XBB variant | SARS-CoV-2 infection and persistence in the human body | Long-term cardiovascular outcomes of COVID-19 | Heart-disease risk soars | Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants | Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines |
Time to negative PCR conversion among high-risk patients | The Fc-effector function of COVID-19 convalescent plasma | Infectiousness of SARS-CoV-2 breakthrough infections and reinfections

January 5, 2023 Read More »

December 29, 2022

Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron | Structural brain changes in post-acute COVID-19 patients | Persistent post–COVID-19 smell loss | Persistent symptoms and sequelae after SARS-CoV-2 infection | VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System | Molnupiravir plus usual care versus usual care alone as early treatment for adults | Higher dose corticosteroids in hospitalized COVID-19 patients | FDA approves Roche’s Actemra (tocilizumab) for the treatment of COVID-19 | Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine | Canine real-time detection of SARS-CoV-2 infections | Clinical Validation of a Novel T-Cell Receptor | Modelling the adjustment of COVID-19 response | Two masks can be worse than one: N95 respirator failure caused by an overlying face mask | Airflow Patterns in Double-Occupancy Patient Rooms | The epidemiology of long COVID in US adults

December 29, 2022 Read More »

December 22, 2022

Immunological dysfunction persists for 8 months |
Clinical Features and Burden of Post-Acute Sequelae of SARS-CoV-2 Infection |
Demonstration of stable clusters of symptoms | Longitudinal Analysis of T cells in COVID-19 |
Reconsideration of anti-nucleocapsid IgG antibody | Early Estimates of Bivalent mRNA Vaccine |
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated
Hospitalization | Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations |
COVID-19 Convalescent Plasma Outpatient Therapy | Bacterial Co-infection and Empirical Antibiotic Therapy in Patients |
Similar SARS-CoV-2 Ct value distributions in anterior nares versus nasopharyngeal samples |
Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics | The WHO estimates of excess mortality associated with the COVID-19 pandemic |
Impact of SARS-CoV-2 variants on inpatient clinical outcome | Association of Time to Surgery After COVID-19 Infection

December 22, 2022 Read More »

November 24, 2022

Impact of community masking on COVID-19 | Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks | What is the place in therapy for nirmatrelvir/ritonavir? | Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

November 24, 2022 Read More »

Pregnant woman sitting on medical exam table speaking with her doctor both wearing masks

November 16, 2022

Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection or Vaccination in Pregnancy | Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations | Acute and postacute sequelae associated with SARS-CoV-2 reinfection

November 16, 2022 Read More »

People attending an award ceremony

Parasite Without Borders Sponsors Upcoming ASTMH Annual Meeting

For the first time in three years, the American Society of Tropical Medicine & Hygiene (ASTMH) will be holding their Annual Meeting in-person. Thousands of doctors, scientists, researchers, members of academia, nonprofit organizations, and more will gather at the Seattle Convention Center in Seattle, Washington, Sunday, October 30th through Wednesday, November 3rd, for the 71st ASTMH conference.

Parasite Without Borders Sponsors Upcoming ASTMH Annual Meeting Read More »

Sick caucasian guy sits on couch feel unhealthy

September 1, 2022

Clinical Manifestations of Infection with Poliomyelitis Virus | Spike Protein-independent Attenuation of SARS-CoV-2 Omicron Variant in Laboratory Mice | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study | Distinguishing features of Long COVID identified through immune profiling | Unexplained post-acute infection syndromes | Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge | Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children

September 1, 2022 Read More »

Donate to Floating Doctors

Donate to Floating Doctors

Throughout August, September and October, all donations made to Parasites Without Borders will be matched by PWB and donated to Floating Doctors. PWB pledges a minimum donation of $10,000 and will match all of your donations, for a total gift to Floating Doctors of up to $40,000. These donations will help support our shared commitment to reduce the present and future burden of disease in the developing world, and to promote improvements in healthcare delivery worldwide.

Donate to Floating Doctors Read More »

Row triangle Shape Decorative svg added to bottom

Learn more about parasitic diseases and receive updates about Parasites Without Borders' initiatives and developments by subscribing to our newsletter.

Parasites Without Borders

Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.

Donate to Parasites Without Borders Today!

Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos.

Scroll al inicio